Compugen Q2 EPS $(0.02) Beats $(0.07) Estimate, Sales $6.70M
Compugen Q2 EPS $(0.02) Beats $(0.07) Estimate, Sales $6.70M
compugen醫療Q2每股收益爲$(0.02)，超出$(0.07)的估計，銷售額爲$6.70M。
Compugen (NASDAQ:CGEN) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.07) by 71.43 percent. This is a 81.82 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $6.70 million which beat the analyst consensus estimate of $2.49 million by 169.16 percent.
compugen醫療（納斯達克股票代碼：CGEN）報告每股虧損0.02美元，超過分析師的預期（預估虧損0.07美元）71.43%。這比去年同期每股虧損0.11美元增加了81.82%。該公司報告季度銷售額爲670萬美元，超出分析師預期的249萬美元169.16%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間